Table 2 Response of patients with... | American Society of Hematology

Table 2

Response of patients with hematological AD to first-line treatment

	Steroids only	RTX	CSA	RTX + CSA	IVIg	Others
ITP	NR (n = 1) CR (n = 2)	NR (n = 1) CR (n = 2)		NR (n = 1)	NR (n = 1) PR (n = 3)
AIHA	NR (n = 1) PR (n = 2) CR (n = 1)	NR (n = 1) PR (n = 1) PR (n = 2)* CR (n = 5)	CR (n = 2)	PR (n = 1)	NR (n = 1)* PR (n = 1) PR (n = 1)†	CSA + tacrolimus CR (n = 1)
Evans		NR‡ (n = 1) CR (n = 1)	NR (n = 2) PR (n = 1) CR (n = 1)		PR (n = 1) CR (n = 1)	Tacrolimus PR (n = 1)

	Steroids only	RTX	CSA	RTX + CSA	IVIg	Others
ITP	NR (n = 1) CR (n = 2)	NR (n = 1) CR (n = 2)		NR (n = 1)	NR (n = 1) PR (n = 3)
AIHA	NR (n = 1) PR (n = 2) CR (n = 1)	NR (n = 1) PR (n = 1) PR (n = 2)* CR (n = 5)	CR (n = 2)	PR (n = 1)	NR (n = 1)* PR (n = 1) PR (n = 1)†	CSA + tacrolimus CR (n = 1)
Evans		NR‡ (n = 1) CR (n = 1)	NR (n = 2) PR (n = 1) CR (n = 1)		PR (n = 1) CR (n = 1)	Tacrolimus PR (n = 1)

ITP indicates immune thrombocytopenia; AIHA, autoimmune hemolytic anemia; RTX, rituximab; CSA, cyclosporine A; NR, no response; PR, partial response; and CR, complete response.

Received additional plasmapheresis.

†

Received additional CSA.

‡

Received additional cyclophosphamide.

View Large

This Feature Is Available To Subscribers Only